PRETTA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 29.936
NA - Nord America 835
AS - Asia 325
AF - Africa 5
OC - Oceania 2
SA - Sud America 1
Totale 31.104
Nazione #
IT - Italia 29.676
US - Stati Uniti d'America 821
CN - Cina 171
SE - Svezia 117
SG - Singapore 82
NL - Olanda 28
IN - India 26
DE - Germania 25
GB - Regno Unito 23
FI - Finlandia 18
FR - Francia 14
KR - Corea 14
CA - Canada 10
HK - Hong Kong 8
VN - Vietnam 8
BE - Belgio 7
IE - Irlanda 7
ES - Italia 5
IR - Iran 4
JP - Giappone 4
TH - Thailandia 4
UA - Ucraina 4
AT - Austria 3
BZ - Belize 3
GR - Grecia 3
AU - Australia 2
CH - Svizzera 2
MU - Mauritius 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BR - Brasile 1
CZ - Repubblica Ceca 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 31.104
Città #
Cagliari 28.100
Uta 1.406
Boardman 168
Nyköping 104
Chandler 89
Fairfield 85
Ashburn 66
Singapore 52
Shanghai 47
New York 38
Houston 35
Rome 33
Wilmington 32
Seattle 30
Cambridge 28
Woodbridge 26
Amsterdam 22
Pune 21
Los Angeles 20
San Diego 18
Boston 17
Helsinki 17
Beijing 14
Seoul 14
Guangzhou 12
Shenzhen 12
London 10
Toronto 10
Dong Ket 8
Paris 7
Zhengzhou 6
Dublin 5
Hong Kong 5
Jacksonville 5
Menlo Park 5
Ann Arbor 4
Buffalo 4
Dearborn 4
Hefei 4
La Maddalena 4
Nanjing 4
Naples 4
Romainville 4
Sestu 4
Wuhan 4
Wuxi 4
Belize City 3
Brussels 3
Hangzhou 3
Nakano 3
Pamplona 3
Peristeri 3
San Cipriano d'Aversa 3
San Francisco 3
Sassari 3
Turin 3
Vienna 3
Washington 3
Centro 2
Delhi 2
Don Mueang 2
Enna 2
Godo 2
Islington 2
Jiaxing 2
Jinan 2
Jinhua 2
Leuven 2
Livorno 2
Milan 2
Molenbeek-Saint-Jean 2
New Bedfont 2
Norwalk 2
Olbia 2
Piacenza 2
Pisa 2
Redwood City 2
Salerno 2
San Giorgio a Cremano 2
Selargius 2
Sydney 2
Xian 2
Yantai 2
Acton 1
Alexandria 1
Amgaon 1
Ankara 1
Assèmini 1
Augusta 1
Basel 1
Bergamo 1
Bilbao 1
Borås 1
Brno 1
Cavenago di Brianza 1
Chandigarh 1
Clifton 1
Cotonou 1
Dongyang 1
Dubai 1
Totale 30.714
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.095
Molecular-biology-driven treatment for metastatic colorectal cancer 2.564
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.159
New therapeutic targets in pancreatic cancer 1.474
Immunotherapy and Cancer: The Multi-Omics Perspective 1.421
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.364
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.197
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.054
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.015
Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue 838
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 800
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 788
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 784
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 762
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 750
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 736
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer 725
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 685
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 622
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression 569
Uncovering key targets of success for immunotherapy in pancreatic cancer 540
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 536
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 534
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 521
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 504
BRCA-mutant pancreatic ductal adenocarcinoma 447
Immune Checkpoint Inhibitors in the Treatment of HCC 429
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 393
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 386
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 370
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 333
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 317
Primary adrenal insufficiency induced by immune checkpoint inhibitors: Biological, clinical, and radiological aspects 309
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 285
Patients with early-onset metastatic colorectal cancer as an emerging distinctive clinical and molecular phenomenon 277
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 247
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 204
Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas 178
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects 176
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 141
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 124
A new prognostic score for biliary tract cancer: a multicenter experience 89
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 76
Fentanyl pectin nasal spray for breakthrough cancer pain treatment: a single center experience 65
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 63
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 62
CD44: A New Prognostic Marker in Colorectal Cancer? 60
Medical management of malignant bowel obstruction: our center experience 59
Artificial Intelligence Models for the Detection of Microsatellite Instability from Whole-Slide Imaging of Colorectal Cancer 54
null 47
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 44
Totale 31.272
Categoria #
all - tutte 42.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020821 0 0 0 12 254 210 182 35 20 33 23 52
2020/20214.569 78 143 108 1.502 869 530 186 310 140 289 252 162
2021/20222.042 127 87 24 97 119 135 96 187 170 229 334 437
2022/20235.088 400 643 563 372 376 438 226 395 436 543 460 236
2023/20245.693 262 188 191 285 445 895 977 435 375 357 589 694
2024/202512.872 5.085 5.741 1.607 439 0 0 0 0 0 0 0 0
Totale 31.272